Target intelligence / Profile preview

Bridging integrator 2 pseudogene

Molecular classification
Pseudogene, Processed, unprocessed, or unitary (exact class for this specific gene not specified, but it falls within the pseudogene category outlined in [1] and [3])
01

Overview

The bridging integrator 2 pseudogene, identified by Ensembl ID ENSG00000249301, is a non-functional genomic sequence closely related to the functional BIN2 (bridging integrator 2) gene. Pseudogenes such as this one do not encode a functional protein product, although some may be transcribed as RNA and potentially participate in regulatory networks. There is no established role for this pseudogene in disease, therapeutic intervention, or as a biomarker. Its presence in gene databases reflects genomic annotation rather than any direct biological or clinical relevance. Pseudogenes are generally classified by their origin as processed, unprocessed, or unitary, and may, in rare cases, contribute to gene regulation or genome evolution, but this has not been demonstrated for ENSG00000249301[1][3][7].

Other names
Bridging integrator 2 pseudogene 1BIN2 pseudogeneBIN2P1
02

Biological functions

Potential transcriptional modulation (as described for some pseudogenes, may affect parental gene regulation or generate noncoding RNA)Other (no function demonstrated specifically for this pseudogene)
03

Disease associations

Other (no direct role in disease, though pseudogenes in general may have regulatory functions or be used as biomarkers in some contexts)
04

Biomarkers

Other (pseudogenes are sometimes studied as biomarkers in research, but no evidence for this specific gene)

Beyond the preview

Go deeper on Bridging integrator 2 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bridging integrator 2 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call